Showing results (131-140 of 139) with videos related to
Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 139 results.
American Journal of Epidemiology|December 1, 1982
Association arrays for comparing familial total cholesterol, high density lipoprotein cholesterol, and triglyceride similarity in the Israeli population by country of originS Karlin, D Carmelli, Y Friedlander, et al.Nucleic Acids Research|August 11, 1993
Comparative DNA sequence features in two long Escherichia coli contigsL R Cardon, C Burge, G A Schachtel, et al.Journal of Molecular Evolution|December 1, 1991
Evidence for selective evolution in codon usage in conserved amino acid segments of human alphaherpesvirus proteinsG A Schachtel, P Bucher, E S Mocarski, et al.The Journal of Urology|September 23, 2003
Safety and efficacy of vardenafil for the treatment of men with erectile dysfunction after radical retropubic prostatectomyGerald Brock, Ajay Nehra, Larry I Lipshultz, et al.Clinical Therapeutics|May 4, 2010
Effectiveness, pharmacokinetics, and safety of a new sustained-release leuprolide acetate 3.75-mg depot formulation for testosterone suppression in patients with prostate cancer: a Phase III, open-label, international multicenter studyMichael Marberger, Amir V Kaisary, Neal D Shore, et al.Molecular Genetics and Metabolism|September 15, 2009
Treatment reduces or stabilizes brain imaging abnormalities in patients with MPS I and IIRaymond Y Wang, Elizabeth Jane Cambray-Forker, Kirk Ohanian, et al.Mayo Clinic Proceedings|August 4, 2012
Avanafil for the treatment of erectile dysfunction: a multicenter, randomized, double-blind study in men with diabetes mellitusIrwin Goldstein, LeRoy A Jones, Laurence H Belkoff, et al.American Journal of Epidemiology|December 1, 1982
Association arrays for the study of familial height, weight, lipid, and lipoprotein similarity in three West Coast populationsS Karlin, P T Williams, J W Farquhar, et al.Urology|November 16, 2005
Open-label trial evaluating the safety and efficacy of zoledronic acid in preventing bone loss in patients with hormone-sensitive prostate cancer and bone metastasesThomas J Polascik, Robert W Given, Charles Metzger, et al.Pageof 14